HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The management of acute mastoiditis in children with cochlear implants: saving the device.

AbstractOBJECTIVE:
Early treatment of profound bilateral sensorineural hearing loss with cochlear implantation has become routine, resulting in an increased proportion of children implanted at younger ages. These children are at a relatively high risk for acute otitis media (AOM), and are more likely to develop mastoiditis in the implanted ear. Despite the significant risks associated with mastoiditis, including compromise of the implant, there are no specific guidelines on the management of this population. We propose a treatment algorithm emphasizing early but conservative operative intervention.
METHODS:
A retrospective chart review included eight patients, who experienced mastoiditis, in the context of cochlear implantation at our center from August 2005 to November 2012. During this period 806 implant surgeries were completed.
RESULTS:
The median age at which mastoiditis occurred was 37 months, and the mean time from implantation to mastoiditis was 9.56 months. All patients underwent drainage of the middle ear in conjunction with intravenous antibiotics, and two additionally underwent post-auricular incision and drainage.
DISCUSSION:
Recent mastoidectomy may be a risk factor for the development of a post-auricular abscess in children, who develop AOM following cochlear implantation. A treatment algorithm was developed, which emphasizes early operative drainage in conjunction with aggressive antibiotic therapy. Conclusions A consistent approach to the management of mastoiditis in children with cochlear implants has not been established. Rapid initiation of aggressive antibiotic therapy and a low threshold for conservative operative intervention results in effective resolution of infection while allowing preservation of the implant.
AuthorsHeather A Osborn, Sharon L Cushing, Karen A Gordon, Adrian L James, Blake C Papsin
JournalCochlear implants international (Cochlear Implants Int) Vol. 14 Issue 5 Pg. 252-6 (Nov 2013) ISSN: 1754-7628 [Electronic] England
PMID23998418 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Cephalosporins
  • Clindamycin
  • cefprozil
  • Amoxicillin-Potassium Clavulanate Combination
  • Cefuroxime
  • Cephalexin
Topics
  • Acute Disease
  • Amoxicillin-Potassium Clavulanate Combination (administration & dosage)
  • Anti-Bacterial Agents (administration & dosage)
  • Cefuroxime (administration & dosage)
  • Cephalexin (administration & dosage)
  • Cephalosporins (administration & dosage)
  • Child
  • Child, Preschool
  • Clindamycin (administration & dosage)
  • Cochlear Implantation (adverse effects)
  • Cochlear Implants (adverse effects, microbiology)
  • Drainage
  • Female
  • Hearing Loss, Sensorineural (surgery)
  • Humans
  • Infant
  • Infusions, Intravenous
  • Male
  • Mastoiditis (drug therapy, epidemiology, etiology)
  • Otitis Media (drug therapy, epidemiology, etiology)
  • Prosthesis-Related Infections (drug therapy, epidemiology, etiology)
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: